{
    "title": "Alnylam RNAi drug reverses progress of rare fatal disease - study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5043339/Alnylam-RNAi-drug-reverses-progress-rare-fatal-disease--study.html",
    "date": "2017-11-02",
    "keywords": [
        "improvement",
        "patisiran",
        "percent",
        "drug",
        "gene",
        "bill",
        "berkrot",
        "hattr",
        "amyloidosis",
        "trial",
        "disease",
        "progression",
        "scale",
        "placebo",
        "life",
        "side",
        "half",
        "disorder",
        "inc",
        "technology",
        "stage",
        "study",
        "condition",
        "attr",
        "polyneuropathy",
        "partnership",
        "sanofi",
        "alnylam",
        "september",
        "thomson",
        "infusion",
        "halt",
        "impairment",
        "average",
        "meeting",
        "paris",
        "difference",
        "addition",
        "quality",
        "worsening",
        "group",
        "measure",
        "profound",
        "need",
        "treatment",
        "lead",
        "investigator",
        "statement",
        "clinician",
        "impact",
        "class",
        "interference",
        "rnai",
        "mutation",
        "gut",
        "heart",
        "damage",
        "tissue",
        "range",
        "expectancy",
        "liver",
        "option",
        "approval",
        "year",
        "end",
        "europe",
        "edema",
        "reaction",
        "patient",
        "discontinuation",
        "case",
        "diarrhea",
        "reporting",
        "david",
        "gregorio"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}